119 related articles for article (PubMed ID: 16189125)
1. Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes.
von Eiff C; Friedrich AW; Becker K; Peters G
Antimicrob Agents Chemother; 2005 Oct; 49(10):4372-4. PubMed ID: 16189125
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301
[TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
von Eiff C; Peters G
J Antimicrob Chemother; 1999 Apr; 43(4):569-73. PubMed ID: 10350389
[TBL] [Abstract][Full Text] [Related]
4. Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.
Lemaire S; Kosowska-Shick K; Appelbaum PC; Glupczynski Y; Van Bambeke F; Tulkens PM
J Antimicrob Chemother; 2011 Mar; 66(3):596-607. PubMed ID: 21186193
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
Guna R; Muñoz C; Domínguez V; García-García A; Gálvez J; de Julián-Ortiz JV; Borrás R
J Antimicrob Chemother; 2005 Jun; 55(6):950-3. PubMed ID: 15824090
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.
Idelevich EA; Kriegeskorte A; Stubbings W; Kahl BC; Peters G; Becker K
J Antimicrob Chemother; 2011 Dec; 66(12):2809-13. PubMed ID: 21948963
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ceftobiprole against coagulase-negative staphylococci isolated in the USA.
Srinivasan V; McGowan JE; McAllister S; Tenover FC
Int J Antimicrob Agents; 2008 Mar; 31(3):294-6. PubMed ID: 18180145
[No Abstract] [Full Text] [Related]
8. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.
Rouse MS; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):363-5. PubMed ID: 17449212
[TBL] [Abstract][Full Text] [Related]
9. Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci.
Dandache P; Moise PA; Orsini J; Montecalvo M; Sakoulas G
J Antimicrob Chemother; 2009 Nov; 64(5):1114-5. PubMed ID: 19734169
[No Abstract] [Full Text] [Related]
10. LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).
Flamm RK; Farrell DJ; Mendes RE; Ross JE; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):54-61. PubMed ID: 22704791
[TBL] [Abstract][Full Text] [Related]
11. Linezolid-resistant Staphylococcus spp. at a tertiary care hospital of Andhra Pradesh.
Kalawat U; Sharma KK; Reddy S
Indian J Med Microbiol; 2011; 29(3):314-5. PubMed ID: 21860120
[No Abstract] [Full Text] [Related]
12. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: an 11-year report from the SENTRY Antimicrobial Surveillance Program.
Jones RN; Farrell DJ; Sader HS
Int J Antimicrob Agents; 2011 Jun; 37(6):584-5. PubMed ID: 21497060
[No Abstract] [Full Text] [Related]
14. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
15. Activity of ceftobiprole compared with those of other agents against Staphylococcus aureus strains with different resistotypes by time-kill analysis.
Lin G; Appelbaum PC
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):233-5. PubMed ID: 17997257
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
17. Sepsis due to linezolid resistant Staphylococcus cohnii and Staphylococcus kloosii: first reports of linezolid resistance in coagulase negative staphylococci from India.
Peer MA; Nasir RA; Kakru DK; Fomda BA; Bashir G; Sheikh IA
Indian J Med Microbiol; 2011; 29(1):60-2. PubMed ID: 21304198
[TBL] [Abstract][Full Text] [Related]
18. Linezolid resistance in coagulase-negative staphylococci.
Kelly S; Collins J; Davin M; Gowing C; Murphy PG
J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
[No Abstract] [Full Text] [Related]
19. A dual outbreak of bloodstream infections with linezolid-resistant Staphylococcus epidermidis and Staphylococcus pettenkoferi in a liver Intensive Care Unit.
Mihaila L; Defrance G; Levesque E; Ichai P; Garnier F; Derouin V; Decousser JW; Doucet-Populaire F; Bourgeois-Nicolaos N
Int J Antimicrob Agents; 2012 Nov; 40(5):472-4. PubMed ID: 22883415
[No Abstract] [Full Text] [Related]
20. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
Livermore DM; Mushtaq S; Warner M; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
